Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Gross Margin (2016 - 2025)

Historic Gross Margin for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to 62.93%.

  • Dexcom's Gross Margin rose 40400.0% to 62.93% in Q4 2025 from the same period last year, while for Dec 2025 it was 60.1%, marking a year-over-year decrease of 3600.0%. This contributed to the annual value of 60.1% for FY2025, which is 3600.0% down from last year.
  • According to the latest figures from Q4 2025, Dexcom's Gross Margin is 62.93%, which was up 40400.0% from 60.48% recorded in Q3 2025.
  • In the past 5 years, Dexcom's Gross Margin ranged from a high of 70.09% in Q2 2021 and a low of 56.85% during Q1 2025
  • In the last 5 years, Dexcom's Gross Margin had a median value of 63.12% in 2022 and averaged 63.37%.
  • As far as peak fluctuations go, Dexcom's Gross Margin soared by 72100bps in 2021, and later tumbled by -55200bps in 2022.
  • Quarter analysis of 5 years shows Dexcom's Gross Margin stood at 67.69% in 2021, then fell by -2bps to 66.4% in 2022, then fell by -4bps to 63.47% in 2023, then decreased by -7bps to 58.9% in 2024, then rose by 7bps to 62.93% in 2025.
  • Its Gross Margin was 62.93% in Q4 2025, compared to 60.48% in Q3 2025 and 59.53% in Q2 2025.